Keyphrases
Pharmacogenetics
100%
Diagnostic Test
100%
Warfarin
100%
Warfarin Therapy
100%
Testing Application
100%
Interactive Modeling
100%
Genotype
45%
Vitamin K Epoxide Reductase
36%
International Normalized Ratio
27%
CYP2C9 Genotype
27%
Patient-specific
18%
CYP2C9
18%
Patient Care
9%
Daily Dose
9%
Pharmacokinetics
9%
Metabolism
9%
Polypeptide
9%
Clinical Information
9%
Concentration-dependent
9%
Quantitative Parameters
9%
Clearance Rate
9%
Cytochrome P450 (CYP450)
9%
Course of Action
9%
Pharmacodynamics
9%
Progressive Change
9%
Specific Course
9%
Decision Support Tool
9%
Ratio Estimation
9%
Genotype-guided
9%
Maintenance Dose
9%
Subfamily C
9%
Temporal Parameters
9%
Actual Measurement
9%
Steady-state Plasmas
9%
Pharmacokinetic-pharmacodynamic Modeling
9%
Computational Decision Support
9%
Multivariate Equations
9%
Biochemistry, Genetics and Molecular Biology
Pharmacogenetics
100%
Genotyping
100%
Blood Plasma
75%
CYP2C9
62%
Vitamin K Epoxide Reductase
50%
Pharmacokinetics
25%
Pharmacodynamics
25%
Metabolic Pathway
12%
Steady State
12%
Clearance
12%
Maintenance Drug Dose
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacogenetics
100%
Warfarin
100%
CYP2C9
41%
Vitamin K Epoxide Reductase
33%
Pharmacokinetics
16%
Pharmacodynamics
8%
Polypeptide
8%
Maintenance Dose
8%
Pharmacodynamic Modeling
8%
Cytochrome P450 Family 2
8%